Literature DB >> 1906634

Effect of lactic acid producing bacteria on the human intestinal microflora during ampicillin treatment.

F Black1, K Einarsson, A Lidbeck, K Orrhage, C E Nord.   

Abstract

20 healthy volunteers participated in a double blind study concerning the effect of lactic acid producing bacteria on the intestinal microflora during ampicillin treatment. 10 volunteers received 500 mg ampicillin tablets t.i.d. together with capsules containing lactic acid producing bacteria (Lactobacillus acidophilus and Bifidobacterium bifidum) for 7 days, and the other 10 volunteers were given 500 mg ampicillin tablets together with placebo capsules t.i.d. for 7 days. Both groups of volunteers continued the intake of the capsules t.i.d. for another 14 days after the ampicillin administration had been completed. The number of enterococci, streptococci and corynebacteria decreased during ampicillin administration but returned to normal levels after 14 days. Yeasts increased during the antibiotic treatment but returned to the same levels as before treatment within 14 days. Escherichia coli strains were suppressed in most volunteers during ampicillin administration. The numbers of anaerobic gram-positive cocci and rods decreased in most subjects during ampicillin treatment but were normalized within 2 weeks. Bacteroides strains were recovered in higher numbers in the lactic acid producing bacteria group compared to the placebo group. The volunteers receiving lactic acid producing bacteria were recolonized slightly faster than those having placebo. There were adverse effects observed in 3 subjects receiving ampicillin plus placebo. In the lactic acid producing bacteria group, one subject had diarrhoea on day 3 to on day 3 to day 7.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906634     DOI: 10.3109/00365549109023408

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  12 in total

1.  Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.

Authors:  E Kheadr; N Dabour; C Le Lay; C Lacroix; I Fliss
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

2.  Influence of a probiotic Lactobacillus casei strain on the colonisation with potential pathogenic streptococci and Staphylococcus aureus in the nasopharyngeal space of healthy men with a low baseline NK cell activity.

Authors:  Charles M A P Franz; Melanie Huch; Stephanie Seifert; Jeannette Kramlich; Achim Bub; Gyu-Sung Cho; Bernhard Watzl
Journal:  Med Microbiol Immunol       Date:  2014-11-23       Impact factor: 3.402

3.  Effects of broad-spectrum antibiotics on colonization of gastrointestinal tracts of mice by Candida albicans.

Authors:  G Samonis; H Anastassiadou; M Dassiou; Y Tselentis; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

4.  Prospective study of the impact of broad-spectrum antibiotics on the yeast flora of the human gut.

Authors:  G Samonis; A Gikas; P Toloudis; S Maraki; G Vrentzos; Y Tselentis; N Tsaparas; G Bodey
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

5.  Mining the microbiota of the neonatal gastrointestinal tract for conjugated linoleic acid-producing bifidobacteria.

Authors:  E Rosberg-Cody; R P Ross; S Hussey; C A Ryan; B P Murphy; G F Fitzgerald; R Devery; C Stanton
Journal:  Appl Environ Microbiol       Date:  2004-08       Impact factor: 4.792

6.  Effect of Lactobacillus acidophilus & epidermal growth factor on experimentally induced Clostridium difficile infection.

Authors:  Sukhminderjit Kaur; Chetana Vaishnavi; Kaushal Kishor Prasad; Pallab Ray; Rakesh Kochhar
Journal:  Indian J Med Res       Date:  2011-04       Impact factor: 2.375

Review 7.  Development of microencapsulation delivery system for long-term preservation of probiotics as biotherapeutics agent.

Authors:  Himanshu K Solanki; Dipak D Pawar; Dushyant A Shah; Vipul D Prajapati; Girish K Jani; Akil M Mulla; Prachi M Thakar
Journal:  Biomed Res Int       Date:  2013-08-21       Impact factor: 3.411

Review 8.  Human gut microbiota: repertoire and variations.

Authors:  Jean-Christophe Lagier; Matthieu Million; Perrine Hugon; Fabrice Armougom; Didier Raoult
Journal:  Front Cell Infect Microbiol       Date:  2012-11-02       Impact factor: 5.293

9.  Long-term use of probiotics Lactobacillus and Bifidobacterium has a prophylactic effect on the occurrence and severity of pouchitis: a randomized prospective study.

Authors:  Banasiewicz Tomasz; Stojcev Zoran; Walkowiak Jarosław; Marciniak Ryszard; Grochowalski Marcin; Burdyński Robert; Krokowicz Piotr; Krokowicz Lukasz; Paszkowski Jacek; Gronek Piotr; Pyda Przemysław; Drews Michał
Journal:  Biomed Res Int       Date:  2014-01-21       Impact factor: 3.411

10.  Influence of different probiotic lactic Acid bacteria on microbiota and metabolism of rats with dysbiosis.

Authors:  Elena Ermolenko; Ludmila Gromova; Yuri Borschev; Anna Voeikova; Alena Karaseva; Konstantin Ermolenko; Andrei Gruzdkov; Alexander Suvorov
Journal:  Biosci Microbiota Food Health       Date:  2013-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.